The ASCO and ASH Update Guideline on Epoetin and Darbepoetin Treatment for Adults with Cancer guideline was recently updated to reflect results of recent clinical studies and a new meta-analysis that used individual patient data from randomized trials. The update also summarizes changes to the U.S. Food and Drug Administration's (FDA's) approved prescribing recommendations. The full guideline and the accompanying clinical tools and resources can be found at www.asco.org/guidelines/esa.
Additionally, Cancer.Net offers an easy-to-read summary of this guideline to help your patients understand and talk about the recommendations. It is available online or as a downloadable PDF at www.cancer.net/whattoknow.